Anda, Inc. — also referred to simply as Anda — is a U.S. pharmaceutical wholesale distributor founded in 1992 and headquartered at 2915 Weston Road, Weston, Florida (some databases list the parent's Parsippany, New Jersey address). It is a wholly owned subsidiary of Teva Pharmaceutical Industries Ltd. (NYSE: TEVA), which acquired the business from Allergan plc for $500 million, completing the deal in October 2016. At the time of sale, reports put the company at roughly 650 employees with about $1.5 billion in 2016 third-party net revenue; it is commonly described as the fourth-largest generic drug wholesaler in the U.S. Anda does not itself manufacture pharmaceuticals.
Operations. Anda distributes generic, brand and specialty pharmaceuticals, injectables, vaccines and biologics, point-of-care diagnostic tests, medical and surgical supplies, OTC products, vitamins and nutritional supplements, and prescription/OTC pet medications — roughly 14,000 SKUs sourced from several hundred manufacturers. Customers include independent and chain retail pharmacies, long-term care pharmacies and facilities, mail-order pharmacies, hospitals, clinics and physician offices across all 50 states, Puerto Rico and the U.S. Virgin Islands. Distribution centers are located in Weston, FL; Groveport, OH; and Olive Branch, MS.
Litigation posture. This is an operating company, not a patent assertion entity. Across the tracked data it appears once — as a defendant, never as a plaintiff — consistent with a distributor pulled into supplier patent disputes rather than an entity asserting patents. Its single tracked matter sits in the U.S. District Court for the District of New Jersey, not a plaintiff-friendly venue such as the Eastern District of Texas.
Notable case. Celgene Corporation v. Natco Pharma Ltd. et al. (D.N.J., No. 2:10-cv-05197, filed Oct. 8, 2010) is Hatch-Waxman ANDA litigation over generic lenalidomide (Revlimid). The original complaint named only Natco Pharma; Anda appears later in the pleadings and the May 2014 stipulation alongside Watson/Actavis entities, reflecting its role as a distribution and marketing partner for the generic product.